An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
Under by Disease Indication, the global market is segmented into Central Nervous System (CNS) Diseases, Gastrointestinal (GI) Diseases, Cardiovascular (CVS) Diseases and Others. CNS Diseases segment will hold maximum revenue share in the global market, and the consumption proportion is about 53.6% in 2018. and forecasts indicate a 54.2% market share for this segment by the end of the forecast period in 2025. North America is the largest consumption place, with a consumption market share nearly 44.99% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 33.84%, China is also an important sales region for the Orally Disintegrating Tablet.

Market Analysis and Insights: Global Orally Disintegrating Tablet Market
In 2019, the global Orally Disintegrating Tablet market size was US$ 9681.2 million and it is expected to reach US$ 18760 million by the end of 2026, with a CAGR of 9.8% during 2021-2026.
Global Orally Disintegrating Tablet Scope and Market Size
Orally Disintegrating Tablet market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Orally Disintegrating Tablet market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026.

Segment by Type, the Orally Disintegrating Tablet market is segmented into
Anti-Psychotics Drug
Anti-Epileptics Drug
Other

Segment by Application, the Orally Disintegrating Tablet market is segmented into
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Other

Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Competitive Landscape

and Orally Disintegrating Tablet Market Share Analysis
Orally Disintegrating Tablet market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2015-2020. Details included are company description, major business, Orally Disintegrating Tablet product introduction, recent developments, Orally Disintegrating Tablet sales by region, type, application and by sales channel.

The major companies include:
GSK
Otsuka
Mylan
Teva
Pfizer
Eli Lilly and Company
Merck
Eisai
AstraZeneca
Bristol-Myers Squibb
Conquer